Shell Asset Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $80K | Sell |
5,398
-580
| -10% | -$8.6K | ﹤0.01% | 1052 |
|
2025
Q1 | $107K | Sell |
5,978
-69
| -1% | -$1.24K | 0.01% | 998 |
|
2024
Q4 | $105K | Sell |
6,047
-301
| -5% | -$5.23K | ﹤0.01% | 1042 |
|
2024
Q3 | $89K | Buy |
+6,348
| New | +$89K | ﹤0.01% | 1072 |
|
2024
Q1 | $55K | Sell |
6,704
-452
| -6% | -$3.71K | ﹤0.01% | 1145 |
|
2023
Q4 | $64K | Sell |
7,156
-2,151
| -23% | -$19.2K | ﹤0.01% | 1138 |
|
2023
Q3 | $83K | Sell |
9,307
-147
| -2% | -$1.31K | ﹤0.01% | 1120 |
|
2023
Q2 | $145K | Sell |
9,454
-54
| -0.6% | -$828 | 0.01% | 1024 |
|
2023
Q1 | $214K | Sell |
9,508
-33
| -0.3% | -$743 | 0.01% | 905 |
|
2022
Q4 | $201K | Sell |
9,541
-1,936
| -17% | -$40.8K | 0.01% | 946 |
|
2022
Q3 | $283K | Sell |
11,477
-3,008
| -21% | -$74.2K | 0.01% | 855 |
|
2022
Q2 | $351K | Buy |
14,485
+24
| +0.2% | +$582 | 0.01% | 901 |
|
2022
Q1 | $373K | Sell |
14,461
-2,140
| -13% | -$55.2K | 0.01% | 952 |
|
2021
Q4 | $515K | Buy |
16,601
+74
| +0.4% | +$2.3K | 0.01% | 887 |
|
2021
Q3 | $401K | Sell |
16,527
-710
| -4% | -$17.2K | 0.01% | 965 |
|
2021
Q2 | $251K | Buy |
17,237
+930
| +6% | +$13.5K | ﹤0.01% | 1174 |
|
2021
Q1 | $407K | Buy |
16,307
+9,426
| +137% | +$235K | 0.01% | 936 |
|
2020
Q4 | $188K | Hold |
6,881
| – | – | ﹤0.01% | 1131 |
|
2020
Q3 | $127K | Hold |
6,881
| – | – | ﹤0.01% | 1135 |
|
2020
Q2 | $140K | Sell |
6,881
-71
| -1% | -$1.45K | ﹤0.01% | 1100 |
|
2020
Q1 | $101K | Sell |
6,952
-105
| -1% | -$1.53K | ﹤0.01% | 1118 |
|
2019
Q4 | $100K | Sell |
7,057
-149
| -2% | -$2.11K | ﹤0.01% | 1184 |
|
2019
Q3 | $84K | Sell |
7,206
-62
| -0.9% | -$723 | ﹤0.01% | 1202 |
|
2019
Q2 | $146K | Sell |
7,268
-165
| -2% | -$3.32K | ﹤0.01% | 1147 |
|
2019
Q1 | $168K | Hold |
7,433
| – | – | ﹤0.01% | 1124 |
|
2018
Q4 | $168K | Sell |
7,433
-600
| -7% | -$13.6K | ﹤0.01% | 1059 |
|
2018
Q3 | $231K | Buy |
+8,033
| New | +$231K | ﹤0.01% | 1093 |
|